Ignite Creation Date:
2025-12-24 @ 11:18 PM
Ignite Modification Date:
2026-01-03 @ 8:07 PM
Study NCT ID:
NCT01226056
Status:
SUSPENDED
Last Update Posted:
2010-10-21
First Post:
2010-10-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sorafenib in Combination With RAD001 in Advanced Solid Tumors Selected on Molecular Targets
Sponsor:
Southern Europe New Drug Organization
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
S075SORD01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Scientific Director
Old Organization:
SENDO